Study of EQU-001 for Uncontrolled Focal Onset Seizures
Public ClinicalTrials.gov record NCT05473442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures
Study identification
- NCT ID
- NCT05473442
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Equilibre Biopharmaceuticals B.V.
- Industry
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Interventions
- EQU-001 Drug
- Matching Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2022
- Primary completion
- Jun 30, 2023
- Completion
- Jun 30, 2023
- Last update posted
- Dec 20, 2023
2022 – 2023
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Consultants in Epilepsy and Neurology, PLLC | Boise | Idaho | 83702 | — |
| Mid-Atlantic Epilepsy and Sleep Center | Bethesda | Maryland | 20817 | — |
| Institute of Neurology and Neurosurgery at Saint Barnabas | Livingston | New Jersey | 07039 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Sooner Clinical Research, Inc. | Oklahoma City | Oklahoma | 73112 | — |
| Comprehensive Epilepsy Center at Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Northwest Houston Neurology | Cypress | Texas | 77429 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05473442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05473442 live on ClinicalTrials.gov.